BridgeBio Pharma - 5 Year Stock Price History | BBIO

Historical daily share price chart and data for BridgeBio Pharma since 2019 adjusted for splits and dividends. The latest closing stock price for BridgeBio Pharma as of October 31, 2024 is 23.41.
  • The all-time high BridgeBio Pharma stock closing price was 72.35 on February 08, 2021.
  • The BridgeBio Pharma 52-week high stock price is 44.32, which is 89.3% above the current share price.
  • The BridgeBio Pharma 52-week low stock price is 21.62, which is 7.6% below the current share price.
  • The average BridgeBio Pharma stock price for the last 52 weeks is 29.33.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
BridgeBio Pharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 28.6736 40.4500 40.4500 23.0000 23.4100 -42.01%
2023 21.3429 7.1700 43.8900 7.1700 40.3700 429.79%
2022 9.6533 17.1600 17.1600 5.2100 7.6200 -54.32%
2021 54.4717 63.6400 72.3500 11.3800 16.6800 -76.54%
2020 35.3461 33.2200 71.1100 16.1100 71.1100 102.88%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $4.791B $0.009B
BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
Bausch Health Cos (BHC) Canada $3.590B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00